HK1246333A1 - 製備具有優異的肽和蛋白結合性質的接枝共聚物賦形劑的方法 - Google Patents
製備具有優異的肽和蛋白結合性質的接枝共聚物賦形劑的方法Info
- Publication number
- HK1246333A1 HK1246333A1 HK18105676.0A HK18105676A HK1246333A1 HK 1246333 A1 HK1246333 A1 HK 1246333A1 HK 18105676 A HK18105676 A HK 18105676A HK 1246333 A1 HK1246333 A1 HK 1246333A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- graft
- production
- protein binding
- binding property
- polymer excipient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
- C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
- C08G81/024—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G
- C08G81/025—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G containing polyether sequences
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/48—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0206—Polyalkylene(poly)amines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyamides (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462074356P | 2014-11-03 | 2014-11-03 | |
PCT/US2015/058885 WO2016073518A1 (en) | 2014-11-03 | 2015-11-03 | Method of production of graft co-polymer excipient with a superior peptide and protein binding property |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1246333A1 true HK1246333A1 (zh) | 2018-09-07 |
Family
ID=55909717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18105676.0A HK1246333A1 (zh) | 2014-11-03 | 2018-05-02 | 製備具有優異的肽和蛋白結合性質的接枝共聚物賦形劑的方法 |
Country Status (11)
Country | Link |
---|---|
US (2) | US10035885B2 (zh) |
EP (1) | EP3215567B1 (zh) |
JP (2) | JP6793641B2 (zh) |
KR (1) | KR102369119B1 (zh) |
CN (1) | CN107531994B (zh) |
AU (1) | AU2015343207B2 (zh) |
BR (1) | BR112017009308B1 (zh) |
CA (1) | CA2966333C (zh) |
ES (1) | ES2875727T3 (zh) |
HK (1) | HK1246333A1 (zh) |
WO (1) | WO2016073518A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3215567B1 (en) | 2014-11-03 | 2021-05-19 | Pharmain Corporation | Method of production of graft co-polymer excipient with a superior peptide and protein binding property |
CN108392625B (zh) * | 2018-03-07 | 2021-10-19 | 武汉轻工大学 | 人心房利钠肽anp在制备癌症治疗药物中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3449946A3 (en) * | 2005-12-19 | 2020-11-04 | PharmaIN Corporation | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
TWI311272B (en) | 2006-01-27 | 2009-06-21 | Asustek Comp Inc | Mouse structure |
CN100374716C (zh) | 2006-03-29 | 2008-03-12 | 严强 | 垂直轴风力发电机叶片安装方法 |
US8563527B2 (en) | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
US20090156459A1 (en) * | 2007-11-16 | 2009-06-18 | Pharmain Corporation | Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
US20090176892A1 (en) * | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
US20110044968A1 (en) * | 2008-03-10 | 2011-02-24 | Pharmal N Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
EP3215567B1 (en) | 2014-11-03 | 2021-05-19 | Pharmain Corporation | Method of production of graft co-polymer excipient with a superior peptide and protein binding property |
-
2015
- 2015-11-03 EP EP15857011.9A patent/EP3215567B1/en active Active
- 2015-11-03 CN CN201580067611.0A patent/CN107531994B/zh active Active
- 2015-11-03 WO PCT/US2015/058885 patent/WO2016073518A1/en active Application Filing
- 2015-11-03 US US15/036,762 patent/US10035885B2/en active Active
- 2015-11-03 CA CA2966333A patent/CA2966333C/en active Active
- 2015-11-03 BR BR112017009308-1A patent/BR112017009308B1/pt active IP Right Grant
- 2015-11-03 AU AU2015343207A patent/AU2015343207B2/en active Active
- 2015-11-03 KR KR1020177015065A patent/KR102369119B1/ko active IP Right Grant
- 2015-11-03 ES ES15857011T patent/ES2875727T3/es active Active
- 2015-11-03 JP JP2017524366A patent/JP6793641B2/ja active Active
-
2018
- 2018-05-02 HK HK18105676.0A patent/HK1246333A1/zh unknown
- 2018-07-09 US US16/030,756 patent/US10882961B2/en active Active
-
2020
- 2020-02-18 JP JP2020025217A patent/JP2020076111A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
BR112017009308A2 (pt) | 2017-12-19 |
EP3215567A1 (en) | 2017-09-13 |
BR112017009308B1 (pt) | 2021-11-03 |
US20180312642A1 (en) | 2018-11-01 |
CA2966333C (en) | 2023-02-14 |
CA2966333A1 (en) | 2016-05-12 |
EP3215567B1 (en) | 2021-05-19 |
CN107531994B (zh) | 2020-12-01 |
AU2015343207A2 (en) | 2017-05-25 |
EP3215567A4 (en) | 2018-07-11 |
US10035885B2 (en) | 2018-07-31 |
AU2015343207B2 (en) | 2019-10-31 |
US10882961B2 (en) | 2021-01-05 |
JP2020076111A (ja) | 2020-05-21 |
JP6793641B2 (ja) | 2020-12-02 |
KR20170109526A (ko) | 2017-09-29 |
KR102369119B1 (ko) | 2022-02-28 |
US20160362523A1 (en) | 2016-12-15 |
ES2875727T3 (es) | 2021-11-11 |
WO2016073518A1 (en) | 2016-05-12 |
CN107531994A (zh) | 2018-01-02 |
JP2018505230A (ja) | 2018-02-22 |
AU2015343207A1 (en) | 2017-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245336A1 (zh) | 用於肽生產的融合伴侶 | |
PL3481216T3 (pl) | Sposób otrzymywania izolatu białka rzepakowego i otrzymany za jego pomocą izolat białka rzepakowego | |
EP3324996A4 (en) | GDF11 BINDING PROTEINS AND USES THEREOF | |
IL252696B (en) | protein production | |
IL249131A0 (en) | A method for reducing the immunogenicity of protein and peptide | |
RS62071B1 (sr) | Bioaktivni protein, njegova primena i postupak za proizvodnju | |
EP3262061C0 (en) | PEPTIDES TO FACILITATE SECRETION AND THEIR USES | |
GB2545376B (en) | Joint part determination method and joint material manufacturing method | |
HUE057808T2 (hu) | Fehérje visszanyerés | |
IL256298A (en) | Multi-specific binding proteins | |
GB201405784D0 (en) | Novel methods, polypeptides and uses thereof | |
GB201414348D0 (en) | Polymers and methods for their production | |
EP3377633C0 (en) | PRODUCTION OF RECOMBINANT PROTEINS | |
GB2543713B (en) | Polymeric proteins and uses thereof | |
EP3147369A4 (en) | Fibroin-like protein production method | |
EP3156145A4 (en) | Molded material production method and molded material | |
ZA201901942B (en) | Nnif and nnif-related peptides and related methods | |
HK1246333A1 (zh) | 製備具有優異的肽和蛋白結合性質的接枝共聚物賦形劑的方法 | |
ZA201901862B (en) | Modified factor h binding protein | |
EP3122904A4 (en) | Detection of high variability regions between protein sequence sets representing a binary phenotype | |
ZA201700867B (en) | Modifying protein production in plants | |
GB201614578D0 (en) | Modified lignin and separation methods | |
EP3241022A4 (en) | Methods for protein and peptide reduction | |
SG11201609815QA (en) | Protein Extraction Methods | |
HK1247132A1 (zh) | 識別medin的抗體 |